Collegium to Participate in Upcoming Investor Conferences
Get Alerts COLL Hot Sheet
Join SI Premium – FREE
STOUGHTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in the following investor conferences:
Jefferies London Healthcare Conference
Fireside Chat Date and Time: Tuesday, November 19, 2024, at 1:30 p.m. GMT
Piper Sandler 36th Annual Healthcare Conference
Fireside Chat Date and Time: Thursday, December 5, 2024, at 1:00 p.m. ET
The fireside chats will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contact:
Danielle Jesse
Director, Investor Relations
[email protected]
Media Contact:
Marissa Samuels
Vice President, Corporate Communications
[email protected]


Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
- Cryptocurrency News: Solana Goes 85x Faster as Pepeto Early Buyers Line Up for a Run
- New Cryptocurrency Picks This Week: Can Solana or Zcash Match the Gains Analysts See in Pepeto?
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share